Orphan Drugs Global Market Report 2022 – By Therapy Area (Oncology, Blood, Central Nervous System, Endocrine, Cardiovascular, Respiratory, Immunomodulatory), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Sales), By Drug Type (Biological, Non-Biological), By Diesease Type (Oncology, Hematology, Neurology, Cardiovascular) – Market Size, Trends, And Global Forecast 2022-2026
What is the definition of the orphan drugs market?
The orphan drugs market consists of sales of orphan drugs and related services that are used to treat rare diseases. An orphan drug is a pharmaceutical drug developed to treat patients suffering from rare diseases and would not make profit if developed commercially.
How will the orphan drugs market drivers and restraints affect orphan drugs market dynamics? What forces will shape the orphan drugs industry going forward?
The orphan drugs market growth is aided by rising prevalence of rare diseases. However, some orphan drugs market restraints include lack of supportive government policies
What is the forecast market size of the orphan drugs market?
The orphan drugs market forecast is expected to reach $183.27 billion in 2025 at a compound annual growth rate of 7%.
How is the orphan drugs market segmented?
The global orphan drugs market is segmented -
1) By Therapy Area: Oncology, Blood, Central Nervous System, Endocrine, Cardiovascular, Respiratory, Immunomodulatory
2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Sales
3) By Drug Type: Biological, Non-Biological
4) By Disease Type: Oncology, Hematology, Neurology, Cardiovascular, Others
Which region has largest share, and what is the market size and growth by geography according to the orphan drugs global market report?
For more detail on this, request a sample here.
Who are the key players of the global orphan drugs market?
Top competitors in the orphan drugs market are Bristol-Myers Squibb Company, Celgene Corporation, F. Hoffmann-La Roche Ltd, Amgen, Biogen, Bayer, Novartis AG, GlaxoSmithKline plc, Johnson & Johnson and AbbVie Inc.
What are the key trends in the global orphan drugs market?
Major trends influencing the orphan drugs market include approval of biological orphan drugs for multiple indication
What are the major opportunities in the orphan drugs market and the approaches companies can take to take advantage of them?
For detail on the future and current opportunities in the global orphan drugs market, request a sample here
How does the orphan drugs market relate to the overall economy and other similar markets?
For this and further detailed insights on the market, request a sample here.